Henlius Hanbeitai Xprt Equipment & Supplies

1 equipment items found

Henlius HANBEITAI - Bevacizumab Injection

Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA

HANBEITAI (bevacizumab injection) was approved by the NMPA in November 2021. It is indicated for metastatic colorectal cancer (mCRC), advanced, metastatic or recurrent non-small cell lung cancer (NSCLC), recurrent glioblastoma, cervical cancer, epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer. It is the only bevacizumab with metastatic colorectal cancer Phase III ...

CONTACT SUPPLIER

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you